The Cell and Gene Therapy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Cell and Gene Therapy Market?
The market size of cell and gene therapy has seen significant growth recently. The market value was $12.01 billion in 2024 and will reach $15.48 billion in 2025, with a compound annual growth rate (CAGR) of 28.9%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Cell and Gene Therapy Industry?
In 2029, the cell and gene therapy market is expected to reach a size of $29.15 billion, growing at a compound annual growth rate (CAGR) of 17.1%.
Download Your Free Sample of the 2025 Cell and Gene Therapy Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Cell and Gene Therapy Market?
The key drivers in the cell and gene therapy market are:
• Rising prevalence of cancer and chronic diseases
• Increasing focus on cell and gene therapy research initiatives
• Heightened investment in advanced technologies and tools such as CRISPR
• Expansion of manufacturing facilities specific to cell and gene therapies.
Global Market Segmentation: Identifying Major Cell and Gene Therapy Industry Segments
The cell and gene therapy market covered in this report is segmented –
1) By Product: Cell Therapy, Gene Therapy
2) By Application: Oncology, Neurological Disorders, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users
Pre-order the 2025 Cell and Gene Therapy Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Cell and Gene Therapy Market?
The key trends in the cell and gene therapy market are:
• Focus on advanced therapies like chimeric antigen receptor (CAR) T-cell therapy is an emerging trend.
• There is a strong trend towards undertaking research initiatives and securing funding.
• Strategic collaborations for technology integration is a growing pattern.
• There's an increasing emphasis on developing gene editing tools, particularly CRISPR.
Who Are the Top Competitors & Leading Players in the Cell and Gene Therapy Market?
Major companies in the cell and gene therapy market are:
• Biogen Inc.
• Novartis AG
• Gilead Sciences
• Ionis Pharmaceuticals Inc.
• Alnylam Pharmaceuticals Inc.
• ArrowHead Pharmaceuticals Inc.
• Spark Therapeutics
• Bluebird Bio Inc.
• RegenexBio
• Mesoblast Limited
• Biocon
• Cipla
• Stempeutics Research Pvt. Ltd.
• EdiGene Inc.
• Immunochina
• Takara Bio
• Daiichi Sankyo Company
• Ultragenyx Pharmaceutical Inc
• Mitsubishi Tanabe Pharma
• Oxford Biomedica plc
• Santen Pharmaceutical Co.
• Therapeutic Innovation Australia
• Merck
• GenScript
• Cellular Biomedicine Group
• GE Healthcare
• inStem
• Lonza
• Nikon CeLL innovation Co. Ltd.
• Bristol-Myers Squibb
• Amgen
• Pfizer
• Kite Pharma
• Oxford BioTherapeutics
• Freeline Therapeutics
• PsiOxus Therapeutics
• Herantis Pharma Plc
• AstraZeneca
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the cell and gene therapy market in 2024
